Is Nabriva Therapeutics (NASDAQ:NBRV) Using Too Much Debt? - Yahoo Finance
2019-09-11 • Google News
Nabriva Therapeutics AG (NBRV)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 4.55M
P/E Ratio
0.00
Revenue (TTM)
$ 36.51M
Volume
0
52W High
$ 0.00
52W Low
$ 0.00
Dividend Yield
0.00%
Beta
1.55
Technicals
50-Day MA
1.373
200-Day MA
1.6667
52 Week High
N/A
52 Week Low
N/A
About NBRV
Nabriva Therapeutics plc, a biopharmaceutical company, engages in the development and commercialization of novel anti-infective agents to treat serious infections. The company's product includes SIVEX.
Employees
39
Headquarters
Dublin, Ireland
CEO
Mr. Theodore R. Schroeder